Platelet Number and Interleukin-6 in Advanced Cancer Patients
Author Information
Author(s): Salgado R, Vermeulen P B, Benoy I, Weytjens R, Huget P, Marck E Van, Dirix L Y
Primary Institution: Angiogenesis Group, Oncological Centre, University of Antwerp
Hypothesis
How do platelet number and interleukin-6 levels correlate with VEGF and bFGF serum levels in advanced cancer patients?
Conclusion
Platelet number and interleukin-6 levels are correlated with VEGF serum levels but not with bFGF in advanced cancer patients.
Supporting Evidence
- Serum VEGF concentration correlated with platelet number.
- Serum IL-6 levels correlated with platelet count and serum VEGF levels.
- Patients with thrombocytosis had significantly higher median VEGF and IL-6 serum concentrations.
- High VEGF and bFGF content in patient sera stimulated endothelial cell proliferation.
Takeaway
This study found that patients with more platelets and higher interleukin-6 levels had more VEGF in their blood, which is important for understanding cancer growth.
Methodology
The study compared platelet numbers and serum concentrations of VEGF, bFGF, and IL-6 in blood samples from advanced cancer patients and measured the effect of patient sera on endothelial cells in vitro.
Participant Demographics
Patients with advanced cancer.
Statistical Information
P-Value
P < 10−4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website